Acute Porphyria Drugs

J07BX01 - Smallpox and Monkeypox Vaccines

Propably not porphyrinogenic
PNP

Rationale
Based on the pharmacokinetics of the smallpox and mpox vaccine, no porphyrinogenic effects are expected.
Chemical description
Live attenuated virus vaccine.
Therapeutic characteristics
Indicated for protection against smallpox, mpox and disease caused by the vaccinia virus. It is administered by a subcutaneous injection.
Metabolism and pharmacokinetics
Vaccines are not metabolized by the cytochrome P450 system.
Similar drugs
Explore alternative drugs in similar therapeutic classes J07B / J07BX or go back.
References
# Citation details PMID
*Government bodies
1. European Medicines Agency (EMA). SmPC Imvanex.
2. Norwegian institute of public health. Vaccines and vaccination.

Tradenames

Imvanex Imvanex vaccine · Jynneos vaccine · Smallpox Vaccine Imvanex Imvanex · Jynneos Imvanex Imvanex Vaccines
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙